GLP-1 medications may affect gut function, appetite signaling, and metabolic health, but also have clear limitations
How does the Retatrutide triple agonist differ from GLP-1 injections like Wegovy
When GLP-1, GLP-2, or VIP were added to these neuronmast-cell co-cultures, researchers observed complete reversal of neuronal death, with all three peptides enhancing neuronal survival in a concentration-dependent manner
Both compounds are developed by Eli Lilly, both target GLP-1 and GIP receptors, but Retatrutide adds a third receptor glucagon creating a triple agonist with superior weight loss results in clinical trials
This initial check-in is important because its when your body is adjusting to the drug, and any early signs of stress on your organs might show up
Holland & Barrett - UK's Leading Health & Wellness Shop